Ozon Pharmaceuticals has launched a new drug, Cephalotriptan, based on the active ingredient eletriptan. The drug is intended for the rapid relief of migraine attacks in adults. The cost of Cephalotriptan is lower than that of the original drug. In addition, the company is the only one on the market offering a large package — 10 tablets (40 mg).